HomeNew CXCR Antagonists

New CXCR Antagonists

Catalog No. Product Name Information
E4650 Ladarixin Ladarixin(DF 2156A free base) is a small molecule, orally available, allosteric and non-competitive antagonist of dual CXCR1 and CXCR2. It is able to reduce the acute and chronic neutrophilic influx, and can be used in research of Asthma, Idiopathic Pulmonary Fibrosis, Influenza-A infection and COPD, cutaneous and uveal melanoma conditions.
F1523 CXCL12/SDF-1 mAb SDF1,SDF-1,SDF1/CXCL12,SDF-1/CXCL12
≡ All CXCR Antagonists